(Q80967319)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Efficacy and tolerability of valsartan in combination with hydrochlorothiazide in essential hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

essential hypertension

1 reference

W D Hall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

R Montoro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

T Littlejohn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

A Jain

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

N Feliciano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

H Zheng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

203-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

Effects of Losartan on a Background of Hydrochlorothiazide in Patients With Hypertension

4 January 2020

cites work

1 reference

12 December 2020

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype

1 reference

12 December 2020

Hydrochlorothiazide and spironolactone in hypertension

1 reference

12 December 2020

Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide

1 reference

12 December 2020

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide

1 reference

12 December 2020

Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension

1 reference

12 December 2020

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine

1 reference

12 December 2020

The angiotensin II type 1 receptor blocker losartan in clinical practice: a review

1 reference

12 December 2020

Valsartan, a new angiotensin II antagonist; blood pressure reduction in essential hypertension compared with an angiotensin converting enzyme inhibitor, enalapril.

1 reference

12 December 2020

The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension

1 reference

12 December 2020

IX-1993 guidelines for management of mild hypertension. WHO/ISH Mild Hypertension Liaison Committee

1 reference

12 December 2020

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril

1 reference

12 December 2020

Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy

1 reference

12 December 2020

Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components

1 reference

12 December 2020

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

1 reference

12 December 2020

Angiotensin receptor antagonists: focus on losartan

1 reference

12 December 2020

10.2165/00044011-199816030-00004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370541%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference